摘要
目的:探讨不同品种的羟丙基甲基纤维素(HPMC)对左金胃漂浮缓释片的漂浮和释药特征的影响,并优选最佳品种。方法:以不同厂家生产的7个HPMC品种为主要辅料制备7种左金胃漂浮缓释片,以起漂时间和持续漂浮时间评价制剂的漂浮性能,以小檗碱和巴马汀体外释放度评价制剂的释放特征。结果:HPMCMK-100000和MK-15000制备的片子快速崩解,不具有漂浮和缓释特征;K-100M和MK-4000所制备的片子起漂时间长,药物释放缓慢;60RT-50、K-4M和MK-1500所制备的片子起漂时间短,持续漂浮时间长,药物释放速度适中,均可作为左金胃漂浮缓释片的亲水凝胶骨架材料。结论:HPMC的品种显著影响左金胃漂浮缓释片的漂浮和释药特征,HPMC60RT-50为最佳品种。
AIM: To elucidate the effect of HPMC on the floating and releasing performances of Zuojin Gastric Floating Sustained-Release Tablets( ZJ -GFST) and to select the optimum matrix adjuvant for ZJ -GFST.METHODS: Seven kinds of ZJ -GFST from pharmaceutical factories as main adjuvant respectively. The floating lag time and the sustained floating time were used to evaluate the floating performance of ZJ - GFST. The accumulative relea- sing rates of berberine and palmatine in vitro were used to evaluate the releasing efficiency of ZJ - GFST. RESULTS : The tablets prepared with HPMC MK - 100000 and MK-15000 disintegrated quickly when contacting with water, and the tablets prepared with HPMC MK-100M and MK-4000 had too long floating lag time and low release speed. The tablets prepared with HPMC 60RT-50,K-4M and MK-1500 all possessed short floating lag time and long sustained floating time and suitable drug releasing rate. CONCLUSION: The selected HPMC is 60RT-50.
出处
《中成药》
CAS
CSCD
北大核心
2007年第7期988-992,共5页
Chinese Traditional Patent Medicine
基金
江苏省方剂研究重点实验室开放课题
南京医药大学科技创新风险基金(CX200602)资助